Transcriptional Regulation of Angiotensinogen Gene

血管紧张素原基因的转录调控

基本信息

  • 批准号:
    7905982
  • 负责人:
  • 金额:
    $ 39.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-08-01 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Hypertension is a serious risk factor for myocardial infarction, heart failure, vascular disease, stroke, and renal failure. The renin-angiotensin system plays an important role in the regulation of blood pressure. Previous studies have suggested that: (a) angiotensinogen (AGT) gene locus is associated with human essential hypertension, (b) variant -6A of the AGT gene is associated with hypertension in Caucasian and Japanese subjects and (c) over-expression of the AGT gene increases blood pressure in transgenic mice. We have found an A/G polymorphism at -217 in the human AGT gene promoter and have shown that frequency of allele A at -217 is significantly increased in African-American hypertensive patients. AGT gene is primarily expressed in the liver and we have shown that reporter constructs containing AGT gene promoter with nucleoside A at -217 have increased basal and IL-6 induced promoter activity on transient transfection in human liver cells. Although hAGT gene has seven polymorphic sites in 1.2Kb region of its promoter, variants -217A almost always occurs with -532T, -793A, and -1074T and variants -217G, -532C, -793G, and -1074G always occur together forming two haplotypes. Since allele - 6A is the predominant allele (frequency 0.85) in African-Americans, AGT gene can be subdivided into four haplotypes -6A:-217A (AA); -6A:-217G (AG); -6G:-217A (GA) and -6G:-217G (GG). However, haplotypes GA and GG are very rare leaving AA and AG as two prominent haplotypes. We have shown that: (a) frequency of AA haplotype is increased in hypertensive patients as compared to the AG haplotype and (b) reporter constructs containing AA haplotype have increased basal as well as IL-6 induced promoter activity as compared to AG haplotype. Since inflammation plays an important role in hypertension, our hypothesis is that increased transcription of AA haplotype of the AGT gene plays an important role in the development of hypertension. In order to prove this hypothesis, we have generated transgenic mice containing human renin gene and either AA or AG haplotype of the hAGT gene using knock-in strategy at the HPRT locus. We have shown that AGT mRNA and protein level is increased in double transgenic mice containing AA haplotype of the AGT gene as compared to the AG haplotype. We have also shown that double transgenic mice containing AA haplotype of the hAGT gene and hRen gene have increased blood pressure as compared to transgenic mice containing AG haplotype of the hAGT gene and hRen gene. We will now study the role of these haplotypes on blood pressure regulation in an in vivo situation in transgenic mice containing either AA or AG haplotype of the hAGT gene and hRen gene but devoid of mAGT gene. PUBLIC HEALTH RELEVANCE: Hypertension is a serious risk factor for myocardial infarction, heart failure, vascular disease, stroke, and renal failure. It is estimated that hypertension affects 50 million Americans with a prevalence rate of 25-30% in the adult Caucasian population. The incidence of hypertension and complications due to hypertension are even greater in the African American population. Our studies will help us understand molecular mechanism involved in hypertension.
描述(由申请人提供):高血压是心肌梗塞,心力衰竭,血管疾病,中风和肾衰竭的严重危险因素。肾素 - 血管紧张素系统在血压调节中起重要作用。先前的研究表明:(a)血管紧张素原(AGT)基因座与人类本质高血压有关,(b)AGT基因的变异-6a与高加索和日本受试者的高血压有关,并且(c)AGT基因的过表达会增加转基因小鼠的血压。我们在人类AGT基因启动子中发现了-217的A/G多态性,并且表明非裔美国人高血压患者的AT -217等位基因A的频率显着增加。 AGT基因主要在肝脏中表达,我们已经表明,含有核苷A AT -217的含有AGT基因启动子的报告基因构建体具有增加的基础和IL -6诱导启动子在人肝细胞中瞬时转染中的启动子活性。尽管HAGT基因在其启动子的1.2kb区域中具有七个多态性位点,但变体-217a几乎总是以-532T,-793A和-793A和-1074T和-1074T和变体-217G,-532C,-532C,-793G,-793G和-1074G始终出现 - 始终出现两种效果。由于等位基因-6a是非裔美国人的主要等位基因(频率为0.85),因此可以将AGT基因细分为四个单倍型-6a:-217a(-217a(AA)); -6A:-217G(AG); -6G:-217A(GA)和-6G:-217G(GG)。但是,单倍型GA和GG非常罕见,将AA和AG作为两种突出的单倍型。我们已经表明:(a)与AG单倍型相比,高血压患者的AA单倍型的频率增加,并且(b)含有AA单倍型的报告基因构建体的基础增加,而IL-6诱导的启动子与AG单倍型相比。由于炎症在高血压中起着重要作用,因此我们的假设是,增加AGT基因的AA单倍型的转录在高血压发展中起着重要作用。为了证明这一假设,我们使用HPRT基因座的敲入策略生成了含有人肾脏基因的转基因小鼠以及AA或Ag单倍型。我们已经表明,与Ag单倍型相比,在含有AGT基因的AA单倍型的双转基因小鼠中,AGT mRNA和蛋白质水平升高。我们还表明,与含有HAGT基因和HREN基因的Ag单倍型相比,HAGT基因和HREN基因的双型单倍型的双转基因小鼠具有升高。现在,我们将研究这些单倍型对血压调节的作用在含有hagt基因和HREN基因的AA或Ag单倍型但没有MAGT基因的转基因小鼠中的体内情况中的作用。公共卫生相关性:高血压是心肌梗塞,心力衰竭,血管疾病,中风和肾衰竭的严重危险因素。据估计,成年高加索人口的高血压影响5000万美国人,患病率为25-30%。在非洲裔美国人口中,高血压和并发症的发生率更大。我们的研究将帮助我们了解与高血压有关的分子机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

ASHOK KUMAR的其他基金

TWEAK/Fn14/UPR Signaling in Skeletal Muscle Wasting
骨骼肌萎缩中的 TWEAK/Fn14/UPR 信号转导
  • 批准号:
    10660397
    10660397
  • 财政年份:
    2023
  • 资助金额:
    $ 39.75万
    $ 39.75万
  • 项目类别:
TAK1 signaling in skeletal muscle
骨骼肌中的 TAK1 信号传导
  • 批准号:
    10201515
    10201515
  • 财政年份:
    2019
  • 资助金额:
    $ 39.75万
    $ 39.75万
  • 项目类别:
TAK1 signaling in skeletal muscle
骨骼肌中的 TAK1 信号传导
  • 批准号:
    10005646
    10005646
  • 财政年份:
    2019
  • 资助金额:
    $ 39.75万
    $ 39.75万
  • 项目类别:
Non-Coding Variants of Angiotensinogen Gene and Hypertension
血管紧张素原基因的非编码变异与高血压
  • 批准号:
    9197334
    9197334
  • 财政年份:
    2016
  • 资助金额:
    $ 39.75万
    $ 39.75万
  • 项目类别:
Non-Coding Variants of Angiotensinogen Gene and Hypertension
血管紧张素原基因的非编码变异与高血压
  • 批准号:
    9325162
    9325162
  • 财政年份:
    2016
  • 资助金额:
    $ 39.75万
    $ 39.75万
  • 项目类别:
MYD88 Signaling in Mammalian Myoblast Fusion
哺乳动物成肌细胞融合中的 MYD88 信号转导
  • 批准号:
    9336240
    9336240
  • 财政年份:
    2015
  • 资助金额:
    $ 39.75万
    $ 39.75万
  • 项目类别:
MYD88 Signaling in Mammalian Myoblast Fusion
哺乳动物成肌细胞融合中的 MYD88 信号转导
  • 批准号:
    9144184
    9144184
  • 财政年份:
    2015
  • 资助金额:
    $ 39.75万
    $ 39.75万
  • 项目类别:
Aldosterone Synthase & Hypertension
醛固酮合酶
  • 批准号:
    9052214
    9052214
  • 财政年份:
    2014
  • 资助金额:
    $ 39.75万
    $ 39.75万
  • 项目类别:
Aldosterone Synthase and Hypertension
醛固酮合酶与高血压
  • 批准号:
    8673375
    8673375
  • 财政年份:
    2014
  • 资助金额:
    $ 39.75万
    $ 39.75万
  • 项目类别:
Aldosterone Synthase & Hypertension
醛固酮合酶
  • 批准号:
    8837685
    8837685
  • 财政年份:
    2014
  • 资助金额:
    $ 39.75万
    $ 39.75万
  • 项目类别:

相似国自然基金

急性期反应蛋白ORM2通过调控巨噬细胞分泌IL-1β促进胆管细胞衰老的作用及机制研究
  • 批准号:
    82300730
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
BAG1/BAG3比值调控缺血性脑卒中急性期UPS和自噬降解错误折叠蛋白质的机制研究
  • 批准号:
    82101372
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
一种重要急性期蛋白的构效耦合及演化机制研究
  • 批准号:
    32071260
  • 批准年份:
    2020
  • 资助金额:
    58 万元
  • 项目类别:
    面上项目
L-阿拉伯糖调节NF-κB通路对糖尿病并脑卒中大鼠血脑屏障的保护机制研究
  • 批准号:
    81701171
  • 批准年份:
    2017
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
急性期蛋白ORM在心力衰竭中的正性肌力作用和机制研究
  • 批准号:
    81773726
  • 批准年份:
    2017
  • 资助金额:
    53.0 万元
  • 项目类别:
    面上项目

相似海外基金

Optimization of a Self-Adjuvanting Particle System for Delivering Respiratory Syncytial Virus Prefusion Protein
用于输送呼吸道合胞病毒预融合蛋白的自我辅助颗粒系统的优化
  • 批准号:
    10666079
    10666079
  • 财政年份:
    2023
  • 资助金额:
    $ 39.75万
    $ 39.75万
  • 项目类别:
p16INK4a+ fibroblasts regulate epithelial regeneration after injury in lung alveoli through the SASP
p16INK4a成纤维细胞通过SASP调节肺泡损伤后的上皮再生
  • 批准号:
    10643269
    10643269
  • 财政年份:
    2023
  • 资助金额:
    $ 39.75万
    $ 39.75万
  • 项目类别:
Selective actin remodeling of sensory neurons for acute pain management
感觉神经元的选择性肌动蛋白重塑用于急性疼痛管理
  • 批准号:
    10603436
    10603436
  • 财政年份:
    2023
  • 资助金额:
    $ 39.75万
    $ 39.75万
  • 项目类别:
Targeting HNF4-induced thrombo-inflammation in Chagas disease
针对恰加斯病中 HNF4 诱导的血栓炎症
  • 批准号:
    10727268
    10727268
  • 财政年份:
    2023
  • 资助金额:
    $ 39.75万
    $ 39.75万
  • 项目类别:
Targeting Menin in Acute Leukemia with Upregulated HOX Genes
通过上调 HOX 基因靶向急性白血病中的 Menin
  • 批准号:
    10655162
    10655162
  • 财政年份:
    2023
  • 资助金额:
    $ 39.75万
    $ 39.75万
  • 项目类别: